| Identification | Back Directory | [Name]
2-AMINO-6-CHLORO-9-(BETA-D-2-DEOXYRIBOFURANOSYL)PURINE | [CAS]
120595-72-4 | [Synonyms]
6-Chloro-2'-deoxyguanosine
2-AMINO-6-CHLOROPURINE-2'-DEOXYRIBOSIDE
2-AMINO-6-CHLOROPURINE-2'-DEOXY-D-RIBOFURANOSIDE
2-Amino-6-chloropurine-9-beta-D-(2'-deoxy)riboside
2-Amino-6-chloropurine-9-beta-D-(2’-deoxy)riboside
2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)purine
2-Amino-6-chloro-9-(β-D-2-deoxyribofuranosyl)
purine
2-Amino-6-chloro-9-(2'-deoxy-b-D-ribofuranosyl)purine
2-AMINO-6-CHLORO-9-(BETA-D-2-DEOXYRIBOFURANOSYL)PURINE
9H-Purin-2-amine, 6-chloro-9-(2-deoxy-β-D-erythro-pentofuranosyl)-
6-Chloro-9-(2-deoxy-β-D-erythro -pentofu ranosyl)-9H -purin-2-amine
(2R,3S,5S)-5-(2-AMino-6-chloro-9H-purin-9-yl)-2-(hydroxyMethyl)tetrahydrofuran-3-ol | [Molecular Formula]
C10H12ClN5O3 | [MDL Number]
MFCD00672274 | [MOL File]
120595-72-4.mol | [Molecular Weight]
285.69 |
| Hazard Information | Back Directory | [Uses]
2-Amino-6-chloropurine-9-beta-D-(2’-deoxy)riboside is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. | [References]
[1] Robak T, Robak P. Purine nucleoside analogs in the treatment of rarer chronic lymphoid leukemias. Curr Pharm Des. 2012;18(23):3373-88. DOI:10.2174/138161212801227005 |
|
| Company Name: |
NewCan Biotech Limited Gold
|
| Tel: |
+86-0571-86912261 +86-15658003402 |
| Website: |
https://www.newcanbio.com/ |
|